Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

U.S. Food and Drug Administration Accepts Takeda’s Supplemental Biologics License Application for Adult Prophylactic Use of VONVENDI [von Willebrand factor (Recombinant)]

firstwordpharmaJune 15, 2021

Tag: Vonvendi , VWF , VIII

PharmaSources Customer Service